
Shared by @newscientist ↗
scientia.global26d ago

In a observational multi-cohort study, Wei Wang and colleagues identify circulating plasma protein signatures of diabetic retinal neurodegeneration (DRN) and translate them into a risk prediction system.
Life Biosciences tests ER-100, a gene therapy that aims to restore vision by rejuvenating damaged retinal neurons.






spectrum.ieee.org10mo ago